Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

Net Loss Per Share - Schedule of Antidilutive (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Employee Stock Options Outstanding [Member]
Schedule of Antidilutive [Line Items]
Antidilutive shares	6,341,712	4,444,220	6,341,712	4,444,220
Unvested Restricted Stock Units [Member]
Schedule of Antidilutive [Line Items]
Antidilutive shares	474,784		474,784
Company Warrants Outstanding [Member]
Schedule of Antidilutive [Line Items]
Antidilutive shares	3,650,214		3,650,214